<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35514798</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">2451-9936</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>26</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>American journal of ophthalmology case reports</Title>
          <ISOAbbreviation>Am J Ophthalmol Case Rep</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Anterior scleritis treated with systemic corticosteroids in Chikungunya infection.</ArticleTitle>
        <Pagination>
          <StartPage>101555</StartPage>
          <MedlinePgn>101555</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">101555</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajoc.2022.101555</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Chikungunya is a matter of grave concern in Brazil. This case report describes a rare ocular manifestation in a patient with chikungunya.</AbstractText>
          <AbstractText Label="CASE REPORT" NlmCategory="UNASSIGNED">A 49-year old male diagnosed with chikungunya one month previously was being treated and followed up by a rheumatologist. He presented with complaints of pain and hyperemia in both eyes over the preceding seven days. Biomicroscopy of both eyes revealed bulbar conjunctival hyperemia 3+/4+ with 360° of ciliary injection, and no other abnormalities. The patient was prescribed 1 drop of loteprednol etabonate every 4 h, tapering every three days, and nimesulide 100 mg every 12 hours for 7 days. One week later, however, scleritis was worse and the medial sclera was elevated, particularly in the right eye. Intraocular pressure remained normal, and hyperemia increased to 4+/4+ in the right eye. Supplementary tests revealed positive serology for chikungunya IgG and IgM antibodies and other etiologies were ruled out. Treatment was then changed to oral prednisone 60 mg/day, tapering every three days. The patient was pain-free three days later with all signs and symptoms having disappeared within five days.</AbstractText>
          <AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Ocular abnormalities resulting from chikungunya virus infection require careful monitoring even after the acute phase of chikungunya infection has passed. The fact that patients usually stop being followed-up after they have been symptomless for some time delays diagnosis and the appropriate treatment of ocular manifestations. Consequently, chikungunya should be included in the differential diagnosis of ocular pathologies wherever the infection is endemic or epidemic.</AbstractText>
          <CopyrightInformation>© 2022 The Authors.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Cruz</LastName>
            <ForeName>João Carlos Gonçalves</ForeName>
            <Initials>JCG</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, Hospital Oftalmológico Visão Laser, 11015-003, Avenida Conselheiro Nébias, 355, Santos, SP, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Moreno</LastName>
            <ForeName>Celso Busnelo</ForeName>
            <Initials>CB</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, Hospital Oftalmológico Visão Laser, 11015-003, Avenida Conselheiro Nébias, 355, Santos, SP, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Colombo-Barboza</LastName>
            <ForeName>Guilherme Novoa</ForeName>
            <Initials>GN</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, Hospital Oftalmológico Visão Laser, 11015-003, Avenida Conselheiro Nébias, 355, Santos, SP, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Colombo-Barboza</LastName>
            <ForeName>Marcello Novoa</ForeName>
            <Initials>MN</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Ophthalmology, Hospital Oftalmológico Visão Laser, 11015-003, Avenida Conselheiro Nébias, 355, Santos, SP, Brazil.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>26</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Am J Ophthalmol Case Rep</MedlineTA>
        <NlmUniqueID>101679941</NlmUniqueID>
        <ISSNLinking>2451-9936</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Arboviruses</Keyword>
        <Keyword MajorTopicYN="N">Chikungunya virus</Keyword>
        <Keyword MajorTopicYN="N">Hyperemia</Keyword>
        <Keyword MajorTopicYN="N">Scleritis</Keyword>
      </KeywordList>
      <CoiStatement>The following authors have no financial disclosures: JCGC, CBM, GNCB, MNCB.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>15</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>6</Day>
          <Hour>5</Hour>
          <Minute>29</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35514798</ArticleId>
        <ArticleId IdType="pmc">PMC9065590</ArticleId>
        <ArticleId IdType="doi">10.1016/j.ajoc.2022.101555</ArticleId>
        <ArticleId IdType="pii">S2451-9936(22)00301-2</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Horwood P.F., Buchy P. Chikungunya. Rev Sci Tech. 2015;34:479–489.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26601450</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Staples J.E., Breiman R.F., Powers A.M. Chikungunya fever: an epidemiological review of a re-emerging infectious disease. Clin Infect Dis. 2009;49:942–948.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19663604</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mahendradas P., Avadhani K., Shetty R. Chikungunya and the eye: a review. J Ophthalmic Inflamm Infect. 2013;3:35.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3605073</ArticleId>
            <ArticleId IdType="pubmed">23514031</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Couderc T., Chrétien F., Schilte C., et al.  A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog. 2008;4:e29.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2242832</ArticleId>
            <ArticleId IdType="pubmed">18282093</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ministry of Health (Brazil)   Ministério da Saúde; Brasília: 2021. Monitoramento dos casos de arboviroses urbanas causados por vírus transmitidos pelo mosquito Aedes (dengue, chikungunya e zika), semanas epidemiológicas 1 a 21, 2021. [Monitoring of cases of urban arboviruses caused by viruses transmitted by the Aedes mosquito (dengue, chikungunya and zika), epidemiological weeks 1 to 21, 2021.]</Citation>
        </Reference>
        <Reference>
          <Citation>Leparc-Goffart I., Nougairede A., Cassadou S., et al.  Chikungunya in the Americas. Lancet. 2014;383:514.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24506907</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Merle H., Donnio A., Jean-Charles A., et al.  Ocular manifestations of emerging arboviruses: dengue fever, Chikungunya, Zika virus, West Nile virus, and yellow fever. J Fr Ophtalmol. 2018;41:e235–e243.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29929827</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Couderc T., Gangneux N., Chrétien F., et al.  Chikungunya virus infection of corneal grafts. J Infect Dis. 2012;206:851–859.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">22706183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mittal A., Mittal S., Bharati M.J., et al.  Optic neuritis associated with Chikungunya virus infection in South India. Arch Ophthalmol. 2007;125:1381–1386.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17923547</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martínez-Pulgarín D.F., Chowdhury F.R., Villamil-Gomez W.E., et al.  Ophthalmologic aspects of chikungunya infection. Trav Med Infect Dis. 2016;14:451–457.</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
